MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Causal effects of sarcopenia-related traits on risk and progression of Parkinson’s disease: a Mendelian randomization study

    T. Wang, J. Geng, R. Han, X. Zeng, J. Peng, YE. Huh (Xi’an, China)

    Objective: To examine causal associations between sarcopenia-related traits and the risk or progression of Parkinson’s disease (PD) using a Mendelian randomization (MR) approach. Background: Previous…
  • 2024 International Congress

    RAB32 variant p.Ser71Arg in the ROstock PArkinson’s Disease Study (ROPAD)

    C. Beetz, M. Radefeldt, K. Tripolszki, P. Bauer (Rostock, Germany)

    Objective: To identify and characterize PD patients with RAB32 variant p.Ser71Arg in the ROstock PArkinson’s Disease Study (ROPAD; ClinicalTrials.gov NCT03866603). Background: A recent preprint provided…
  • 2024 International Congress

    Expanding Phenotype of LRRK2 G2019S Mutation: Case Description of Two Sisters Showing Peculiar Phenomenological Traits

    S. Cartella, S. Neri, G. Foti, G. Cartella (Reggio Calabria, Italy)

    Objective: The aim of this case report is to describe and expand LRRK2 phenomenology, including clinical presentation and disease course. Background: LRRK2 is the most…
  • 2024 International Congress

    Altered EEG Theta Activity Characterizes Parkinson’s disease with Levodopa-induced Dyskinesia

    M. Sciascia, A. Castelnovo, I. Bertaina, C. Desperati, C. Steadler, A. Kaelin, S. Galati (Lugano, Switzerland)

    Objective: We explored the relationship between the build-up and the downscaling process in patients with Parkinson’s disease by analyzing theta frequency spectral bands. Background: During…
  • 2024 International Congress

    Parkinson’s Disease tremor can show entrainment and distractibility with electrophysiological assessment using tapping test.

    T. Grippe, N. Sheth, N. Raies, M. Callister, M. Ding, N. Desai, R. Chen (Toronto, Canada)

    Objective: To examine whether features described in tapping test are specific to functional tremor by evaluating rest and postural tremor in PDpatients using the same protocol for assessment of…
  • 2024 International Congress

    The role of pathology validation on the association between smoking and Parkinson’s Disease

    P. Pecoraro, S. Carbone, F. Alessi, V. Di Lazzaro, L. Di Biase (Rome, Italy)

    Objective: The aim of this study is to investigate the relationship between smoking and Parkinson’s disease in pathology validated Parkinson’s disease patients. Background: Literature has…
  • 2024 International Congress

    A Risk of Thromboembolic Complications In Patients With Parkinson’s Disease

    P. Lisewski, B. Lisewska, N. Słomka, M. Wasilewska, D. Rość (Bydgoszcz, Poland)

    Objective: A small number of reports refer to studies assessing the risk of thromboembolic complications in patients with PD in the form of a stroke,…
  • 2024 International Congress

    Educational Programs for Patients with Parkinson disease and Deep Brain Stimulation: Scoping Riview

    M. Petralito, C. Tedesco, F. Fanari, G. Pucciarelli, R. Caruso (Roma, Italy)

    Objective: Map the literature on educational programs for patients with Parkinson's disease and Deep Brain Stimulation, analysing the characteristics that the programmes have and the…
  • 2024 International Congress

    Behind the Prison Gates – Creating a nurse led Parkinson’s healthcare pathway at HMP Dartmoor Prison, UK.

    E. Edwards, J. Bradley, B. Morgan (Plymouth, United Kingdom)

    Objective: To create an equitable Parkinson’s nurse service for people with Parkinson's detained at a Category C, men’s prison in West Devon, UK. Background: There…
  • 2024 International Congress

    Cytokine Profiles as Biomarkers for Neurodegenerative Diseases: An inflammatory study on Parkinson’s Disease and Tauopathies

    A. Jäck, W. Wilfert, C. Palleis, A. Bernhardt, E. Weidinger, S. Katzdobler, U. Fietzek, D. Teupser, J. Levin (Munich, Germany)

    Objective: To investigate the diagnostic and prognostic value of cytokine profiles in cerebrospinal fluid (CSF) and serum of patients with Parkinson's Disease (PD), Progressive Supranuclear…
  • « Previous Page
  • 1
  • …
  • 51
  • 52
  • 53
  • 54
  • 55
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley